Monohidrato de oxalato dipotásico, mínimo 98%, extra puro, 10 kg, envase de plástico.

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(trifluoromethyl)pyrrolidine-2-carboxylic acid, 95.0%, 10g

2,6-Dichlorophenylthioethanol, 98.0%, 5g

1-(3,5-Dimethylphenyl)-2,2,2-trifluoroethan-1-ol, 97%, 500mg

2,3-Dimethyl-1 H -indole-5-carboxylic acid ethyl ester, 95.0%, 100mg

2-(Hydroxymethyl)anthracene-9,10-dione, 250mg

4-Amino- N -thiophen-2-ylmethyl-benzamide, 95.0%, 250mg

Lenalidomide-propargyl-C2-NH2 (hydrochloride), 5mg

5,6,7,8-Tetrahydroimidazo[1,2-a]pyridine, 97%, 1g

3-(2-aminopyridin-4-yl)propanoic acid, 98%, 1g

2-(3-Chlorophenyl)piperidine, 97%, 1g

2-Pyridin-4-ylmethyl-2H-pyrazol-3-ylamine, 95.0%, 1g

Sodium 2-[2-(4-ethylphenyl)-1,3-thiazol-4-yl]acetate, 97%, 100mg